Prediction of basal glycaemia dynamics during treatment with 6-month lipid-lowering therapy in patients at high risk of cardiovascular disease
Background. A major meta-analysis has confirmed the ability of statins to exert both diabetogenic and hyperglycaemic effects. To date, practical recommendations for predicting glucose dynamics during lipid-lowering therapy have not been developed. Aims. Identify the combination of factors that can...
Guardado en:
Autores principales: | Olga A. Koshelskaya, Anastasiya S. Sushkova, Olga A. Zhuravleva, Irina V. Vinnizkaya, Nataliya G. Brazovskaya, Elena S. Kravchenko, Tatyana E. Suslova, Rostislav S. Karpov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b8e14caef19448168be1bfadedef02f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Causes behind the failure to manage patients with type 2 diabetes mellitus. The role of postprandial glycemia
por: Elena Valer'evna Doskina
Publicado: (2010) -
Topical problems of diabetes treatment during pregnancy
por: Irina Yur'evna Demidova, et al.
Publicado: (2009) -
Is the 1,5-anhydro-D-glucitol test a promising tool for monitoring compensation and treatment of diabetes mellitus?
por: Margarita Ivanovna Arbuzova, et al.
Publicado: (2010) -
Systems of continuous subcutaneous insulin infusion to maintain metabolic compensation for type 1 diabetes mellitus among children and adolescents
por: Elena B. Bashnina, et al.
Publicado: (2019) -
HPLC DETERMINATION OF EZETIMIBE AND SIMVASTATIN IN PHARMACEUTICAL FORMULATIONS
por: ASHFAQ,MUHAMMAD, et al.
Publicado: (2007)